Collplant Biotechnologies Ltd Working Capital to Net Assets Ratio
Collplant Biotechnologies Ltd working capital to net assets ratio. Collplant Biotechnologies Ltd (CLGN) has a Working Capital to Net Assets ratio of 75.1% as of September 2025. Working capital of $6.99 Million (current assets of $9.62 Million minus current liabilities of $2.63 Million) is measured against net assets of $9.30 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check CLGN intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Collplant Biotechnologies Ltd (2012–2024)
Working capital to net assets ratio of Collplant Biotechnologies Ltd from 2012 to 2024. This chart shows how Collplant Biotechnologies Ltd's Working Capital to Net Assets ratio has evolved across 13 annual periods from 2012 to 2024. As of September 2025, the ratio stands at 75.1%, reflecting working capital of $6.99 Million against net assets of $9.30 Million USD. See CLGN cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Collplant Biotechnologies Ltd Working Capital to Net Assets Ratio by Year (2012–2024)
Collplant Biotechnologies Ltd working capital to net assets ratio by year from 2012 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Collplant Biotechnologies Ltd from 2012 to 2024, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see how large is Collplant Biotechnologies Ltd's balance sheet.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 75.8% | $10.21 Million | $13.46 Million | $13.18 Million | $2.97 Million | ▼ -11.6 pp |
| 2023 | 87.4% | $24.77 Million | $28.34 Million | $28.02 Million | $3.25 Million | ▼ -1.0 pp |
| 2022 | 88.5% | $28.55 Million | $32.28 Million | $31.66 Million | $3.10 Million | ▼ -4.8 pp |
| 2021 | 93.2% | $42.07 Million | $45.12 Million | $45.09 Million | $3.01 Million | ▲ +42.1 pp |
| 2020 | 51.1% | $2.29 Million | $4.48 Million | $5.68 Million | $3.39 Million | ▲ +12.4 pp |
| 2019 | 38.7% | $1.58 Million | $4.09 Million | $5.04 Million | $3.46 Million | ▼ -64.3 pp |
| 2018 | 103.0% | $4.90 Million | $4.76 Million | $7.14 Million | $2.23 Million | ▼ -89.6 pp |
| 2017 | 192.6% | $5.03 Million | $2.61 Million | $6.45 Million | $1.42 Million | ▲ +168.1 pp |
| 2016 | 24.5% | $328.34K | $1.34 Million | $2.10 Million | $1.77 Million | ▼ -24.7 pp |
| 2015 | 49.2% | $1.23 Million | $2.51 Million | $2.19 Million | $960.64K | ▼ -20.5 pp |
| 2014 | 69.6% | $2.56 Million | $3.68 Million | $3.24 Million | $679.77K | ▼ -12.8 pp |
| 2013 | 82.4% | $6.41 Million | $7.78 Million | $7.32 Million | $915.72K | ▲ +16.4 pp |
| 2012 | 66.0% | $2.77 Million | $4.20 Million | $3.57 Million | $797.87K | — |